Results 151 to 160 of about 8,552 (184)

Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study. [PDF]

Lancet Reg Health Am
Torres TS, Hoagland B, Coutinho C, Silva MST, Moreira RI, Leite IC, Cunha M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão MPG, Madruga JV, de Lima JN, Zonta R, O'Malley G, Moreira J, Simpson K, Pines HA, Rinehart AR, Pilgrim N, Luz PM, Benedetti M, Pimenta MC, Veloso VG, Grinsztejn B, ImPrEP CAB Brasil Study Group.   +26 more
europepmc   +1 more source

PrEP uptake, persistence, and patterns of choice dynamics between oral and long-acting injectable with cabotegravir among sexually and gender-diverse adolescents in Brazil: a multisite cohort implementation study. [PDF]

Lancet Reg Health Am
Magno L, Leite BO, Zeballos D, Soares F, Dezanet L, Westin M, Tupinambás U, Greco D, Massa P, Grangeiro A, Dourado I, PrEP15-19 Choices Study.   +11 more
europepmc   +1 more source

Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy. [PDF]

Cochrane Database Syst Rev
Cantidio FS, Costa Diniz PH, Gil G, Silva-Filho AL.   +3 more
europepmc   +1 more source

Retreatment after loss of follow-up in adolescent and young adult patients living with HIV: a case-control study. [PDF]

Rev Lat Am Enfermagem
Piran CMG, Cargnin AVE, Mori MM, Oliveira RR, Frade JMG, Furtado MD.   +5 more
europepmc   +1 more source